Picture of Mallinckrodt logo

MNKTQ Mallinckrodt Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Mallinckrodt, fiscal year end - December 30th, USD millions except per share, conversion factor applied.

2018
December 28th
2019
December 27th
2020
December 25th
2021
December 31st
2022
December 30th
Period Length:52 W52 W52 W53 W53 W
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,2163,1632,7492,2091,914
Cost of Revenue
Gross Profit1,4711,4211,205892341
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses6,9374,5183,4622,8402,943
Operating Profit-3,721-1,356-713-631-1,029
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-4,052-1,592-961-830-1,462
Provision for Income Taxes
Net Income After Taxes-3,630-1,007-970-724-912
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-3,607-997-945-717-911
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-3,607-997-945-717-911
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-12.30.86-5.04-2.89-34.4